Privacy-Aware AI for Rare-Disease Patient Discovery and Targeted Outreach: An Effectiveness Study
Published 2024-06-10
Keywords
- Artificial Intelligence,
- Rare Disease Identification,
- Precision Marketing,
- Patient Engagement
How to Cite
Copyright (c) 2024 Spectrum of Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Rare diseases affect millions of patients worldwide, presenting significant challenges in patient identification and targeted marketing of therapeutic interventions. This research proposes an artificial intelligence-driven framework for precise identification of rare disease patients and develops personalized marketing strategies to enhance treatment accessibility. The study integrates multi-source data including electronic health records, social media patterns, and search behaviors to construct machine learning models capable of identifying potential rare disease patients with 89.2% accuracy across five disease categories. The personalized marketing strategies demonstrated a 73% improvement in patient engagement rates and 68% increase in treatment awareness compared to traditional broadcasting approaches. The framework addresses critical gaps in rare disease patient outreach while maintaining ethical standards for data privacy. Results indicate substantial potential for AI-enhanced precision marketing to improve healthcare resource allocation efficiency and accelerate therapeutic adoption among rare disease populations, contributing to reduced diagnostic delays and enhanced patient outcomes.
References
- Brasil, S., Pascoal, C., Francisco, R., dos Reis Ferreira, V., A. Videira, P., & Valadão, G. (2019). Artificial intelligence (AI) in rare diseases: is the future brighter?. Genes, 10(12), 978.
- Dash, B., Sharma, P., & Swayamsiddha, S. (2023, March). Use of AI & embedded technology in human identity chips for IoMT. In 2023 4th International Conference on Computing and Communication Systems (I3CS) (pp. 1-6). IEEE.
- Kuang, A. (2022, July). Construction of personalized advertising accuracy model based on artificial intelligence. In 2022 International Conference on Artificial Intelligence and Autonomous Robot Systems (AIARS) (pp. 395-398). IEEE.
- Budėnaitė, M., Correia, R. F., & Venciūtė, D. (2024). The Influence of Artificial Intelligence on Advertising. In AI Innovation in Services Marketing (pp. 134-149). IGI Global.
- Geethanjali, P., & Ajay, V. (2024, May). Ai-enhanced personal care robot assistant for hospital medication delivery. In 2024 5th International Conference for Emerging Technology (INCET) (pp. 1-8). IEEE.
- Lee, G. H., Lee, K. J., Jeong, B., & Kim, T. (2024). Developing personalized marketing service using generative AI. IEEE Access, 12, 22394-22402.
- Wojtara, M., Rana, E., Rahman, T., Khanna, P., & Singh, H. (2023). Artificial intelligence in rare disease diagnosis and treatment. Clinical and Translational Science, 16(11), 2106-2111.
- Visibelli, A., Roncaglia, B., Spiga, O., & Santucci, A. (2023). The impact of artificial intelligence in the odyssey of rare diseases. Biomedicines, 11(3), 887.
- Gao, B., Wang, Y., Xie, H., Hu, Y., & Hu, Y. (2023). Artificial intelligence in advertising: advancements, challenges, and ethical considerations in targeting, personalization, content creation, and ad optimization. Sage Open, 13(4), 21582440231210759.
- Fuster-Barceló, C., Cámara, C., & Peris-López, P. (2024). ECG-Based Patient Identification: A Comprehensive Evaluation Across Health and Activity Conditions. IEEE Access.
- Berger, A., Lagones, T. A., Grigull, L., Fendrich, L., Bell, T., Högl, H., ... & Lübbering, M. (2024, December). Tackling Data Sparsity and Combinatorial Challenges in Rare Disease Matching with Medical Informed Machine Learning. In 2024 IEEE International Conference on Big Data (BigData) (pp. 6430-6438). IEEE.
- Cohen, A. S., Farrow, E. G., Abdelmoity, A. T., Alaimo, J. T., Amudhavalli, S. M., Anderson, J. T., ... & Pastinen, T. (2022). Genomic answers for children: Dynamic analyses of> 1000 pediatric rare disease genomes. Genetics in Medicine, 24(6), 1336-1348.
- Hurvitz, N., Azmanov, H., Kesler, A., & Ilan, Y. (2021). Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases. European Journal of Human Genetics, 29(10), 1485-1490.
- Kumar, P., Dwivedi, Y. K., & Anand, A. (2023). Responsible artificial intelligence (AI) for value formation and market performance in healthcare: The mediating role of patient's cognitive engagement. Information Systems Frontiers, 25(6), 2197-2220.
- Groft, S. C., Posada, M., & Taruscio, D. (2021). Progress, challenges and global approaches to rare diseases. Acta paediatrica, 110(10), 2711-2716.